disposal occurs in skeletal muscle, whereas fasting plasma glucose levels are determined primarily by glucose output from the liver.
Figure 2. Tyrosine Kinase Substrates of the Insulin Receptor
Insulin stimulates the tyrosine kinase activity of its receptor, leading to the phosphorylation of a number of cellular substrates, including Gab1, Shc, IRS 1-4, and Cbl. Upon phosphorylation, each of these proteins can interact with SH2-containing proteins that direct a pathway of signal transduction. Gab1 appears to interact with the SH2 containing tyrosine phosphatase SHP2, leading to the activation of the MAP kinase pathway. Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway. The IRS family of substrates can interact with a number of SH2 domain proteins. Notable among these is the regulatory subunit of PI 3-kinase, which leads to the activation of PIP 3 -dependent protein kinases such as Akt. This pathway appears to be required for most of the cellular actions of insulin. The insulin receptor can also phosphorylate Cbl, via its recruitment to the receptor by the adaptor protein CAP. Upon phosphorylation, Cbl translocates to the lipid raft subdomain of the plasma membrane, where it interacts with the SH2 domain of the adaptor protein CrkII. This pathway is also necessary for the stimulation of glucose transport by insulin. IRS, insulin receptor substrate; PI-3K, phosphatidylinositol 3-kinase.
stasis (Bruning et al., 2000)
. Although care must be taken subunit of phosphatidylinositol (PI) 3-kinase. Activated PI 3-kinase generates the lipid phosphatidylinositol 3,4,5 in interpretation of metabolic studies in rodent models and their extrapolation to human physiology, these findtrisphosphate (PIP 3 ). Increased PIP 3 leads to the activation of a protein kinase cascade, first stimulating the ings challenge the current view of muscle as the primary site of insulin resistance and suggest an interaction beprotein kinase PDK, which phosphorylates and activates two classes of serine/threonine kinases, Akt (also known tween tissues in the regulation of glucose homeostasis more complex than previously anticipated. Thus, reas protein kinase B [PKB]), and the atypical protein kinase C isoforms and (PKC/) (Figure 2 ). Studies search concentrating only on muscle biopsies to measure the levels or function of genes or proteins involved using pharmacological inhibitors, microinjection of blocking antibodies, and expression of dominant-interfering in insulin action may miss critical defects that have indirect effects through other tissues. mutants indicate a necessary role for PI 3-kinase activity in insulin-stimulated glucose uptake in fat and muscle Insulin Signaling Pathways Although studies on the genetic forms of extreme insulin cells (Czech and Corvera, 1999). To determine the in vivo role of PI 3-kinase in glucose homeostasis, mice resistance in humans and in mouse knockouts have provided a conceptual framework for our understanding were generated with a targeted disruption of the gene encoding the p85 regulatory subunit of PI 3-kinase of insulin action, mutations in the insulin receptor are not common in the general population, suggesting that . Paradoxically, these mice exhibited increased insulin sensitivity and hypoglycemia due to postreceptor defects represent the primary failures of insulin action in diabetes. Once activated, the insulin increased glucose transport in skeletal muscle and adipocytes. Although the significance of these findings is receptor phosphorylates a number of intracellular substrates on tyrosine, including members of the insulin uncertain, it is possible that other isoforms of the regulatory protein are increased in compensatory fashion, receptor substrate family (IRS1/2/3/4), the Shc adaptor protein, Gab-1 and Cbl (Figure 2 ., 1998) . Thus, although PI 3-kinase activation is necessary, there is at least one additional pathin insulin action lies in the uptake and storage of glucose as glycogen in muscle. Although it is likely that these way involved.
The PI 3-kinase-independent pathway might involve observations were reflective of decreased glucose uptake in insulin-resistant subjects, glycogen storage is the tyrosine phosphorylation of the Cbl protooncogene (Ribon and Saltiel, 1997) . This phosphorylation requires typically diminished in patients with Type 2 diabetes, and may represent a critical event in the pathophysiolthe presence of the adaptor protein CAP, which associates with a proline-rich domain in Cbl through its carogy of the disease. Insulin modulates glycogen accumulation through a coordinated increase in glucose transboxy-terminal SH3 domain (Figure 2 ). CAP expression correlates well with insulin responsiveness; it is export and glycogen synthesis (Figure 3 marily increasing PP1 activity localized at the glycogen particle. The compartmentalized activation of PP1 by Glut4 and Glucose Transport Insulin increases glucose transport in fat and muscle insulin is due to glycogen-targeting subunits which serve as "molecular scaffolds." bringing together the cells by stimulating the translocation of the transporter Glut4 from intracellular sites to the plasma membrane. enzyme directly with its substrates glycogen synthase and glycogen phosphorylase in a macromolecular comWhile it is known that insulin-stimulated glucose transport is attenuated in insulin resistance , plex, and in the process exerting profound effects on PP1 activity in a substrate-specific manner (Newgard et our understanding of the precise mechanisms by which insulin directs the translocation of Glut4-containing vesial., 2000). Four different proteins with some overlap in tissue distribution, G M , G L , PTG, and R 6 , have been recles to the cell surface remains incomplete. In the basal state, Glut4 continuously recycles between the cell surported to target PP1 to the glycogen particle. Despite a proposed common function, no two targeting subunits face and various intracellular compartments. Insulin markedly increases the rate of Glut4 vesicle exocytosis, share more than 50% sequence homology, which is largely confined to the PP1-and putative glycogen bindand slightly decreases the rate of internalization. Although the mechanisms are unknown, it is likely that ing regions. Overexpression of these scaffolding proteins in cells or in vivo by adenoviral-mediated gene the Glut4-containing vesicle is tethered to intracellular sites, perhaps defined by a microtubule network (Guiltransfer resulted in a dramatic increase in basal cellular glycogen levels, even when the extracellular media was herme et al., 2000). Phosphorylation events such as those catalyzed by PIP 3 -dependent kinases might release the supplemented with only amino acids in the absence of glucose (Berman et al., 1998). Furthermore, glycogen vesicle from these sites, allowing for trafficking of Glut4 to the cell surface.
stores in the cells infected with PTG were refractory to breakdown by agents that raise intracellular cAMP The v-SNARE protein VAMP2 on Glut4-containing vesicles physically interacts with its t-SNARE counterlevels. These results suggested that PTG overexpression locks the cell into a glycogenic mode (Newgard part syntaxin 4 during Glut4 vesicle docking and fusion with the plasma membrane (Pessin et al., 1999) . One et al., 2000). Thus, although glucose transport is ratelimiting for glycogen synthesis, manipulation of proteins interesting possibility is that the PI 3-kinase-independent arm of insulin action may be directed at the docking involved in the regulation of synthase and its regulators can have profound effects on glucose metabolism. and fusion step of Glut4 regulation. Although these Insulin stimulates the uptake and storage of glucose in fat and muscle cells. The hormone stimulates transport of glucose, which is then phosphorylated by hexokinase, and converted into a substrate for glycogen synthase. This enzyme is regulated by insulin through allosteric and covalent modifications. Insulin produces a net reduction in the phosphorylation state of the enzyme, via inhibition of kinases such as PKA and GSK3, and activation of the phosphatase PP1. Glucose 6-phosphate and UDP-Glucose also allosterically activate the enzyme, and make it a better substrate for dephosphorylation. Glycogen phosphorylase is activated by the calciumdependent phosphorylase kinase, and inactivated by dephosphorylation via PP1. These dephosphorylation events are coordinated by targeting proteins such as PTG, which assembles these proteins at the glycogen pellet into a signal reception module for regulation by insulin. IR, insulin receptor; PP1, protein phosphatase 1; PKA, protein kinase A; GSK3, glycogen synthase kinase 3; GS, glycogen synthase; GP, glycogen phosphorylase; PK, phosphorylase kinase; PTG protein targeting to glycogen; G6P, glucose 6-phosphate; G1P, glucose 1-phosphate; UDPG, UDP-glucose.
In addition to a primary defect in glucose transport, tance of type 2 diabetes were performed with monogenic models of obesity, especially the ob/ob and db/db evidence exists for reduced glycogen synthase activity in certain populations ( 
Cytokines and Insulin Resistance into muscle and liver. Earlier studies (Boden et al., 1994) reported a 3 hr lag in the inhibitory effect of lipid infusion,
In addition to generating increases in fatty acids, the development of obesity may provide other critical sigsuggesting that some metabolism or accumulation of lipid to threshold levels was required. Although all of nals that contribute to insulin resistance. While the central nervous system plays an important role in regulating the studies reported thus far are correlative in nature, one interesting possibility is that fatty acid influx or accuinsulin sensitivity, there is also growing evidence that adipocyte-derived cytokines, particularly TNF␣, might mulation leads to the activation of a serine kinase which phosphorylates IRS1, reducing its tyrosine phosphorylablock insulin action. Some, but not all studies have indicated that TNF␣ may be elevated in states of obesity, tion by the insulin receptor, as discussed above. , 1999) . to the Development of Diabetes As described above, insulin is released from the ␤ cell Genetics of Human Type 2 Diabetes as a consequence of glucose metabolism, and the deGenetic factors profoundly influence insulin sensitivity. velopment of Type 2 diabetes occurs upon the failure Insulin resistance occurs commonly in relatives of type of the ␤ cell to compensate adequately for insulin resis-2 diabetics, and offspring of two type 2 diabetic parents tance by secreting more insulin. Studies in monogenic are invariably insulin resistant. In addition, studies in obese rodent models of Type 2 diabetes have shown a monozygotic twins reveal a high heritability of diabetes, general pattern of expansion of ␤ cell mass to compenwith a 50%-75% estimate in the heritability of insulin sate for increased insulin demand, followed by deresistance. Given that genes influence glucose homeocreased glucose recognition, islet degeneration, destasis, the major question arises as to whether these granulation, and loss of ␤ cells (Cavaghan et al., 2000) .
traits are the consequence of one or two "major' genes, There have been few morphological examinations of or a large number of "minor" genes, that may be expancreata in patients with Type 2 diabetes, yet it is likely pressed only under the appropriate environmental inthat a similar sequelae occurs. Although the mechasults. While this issue remains unresolved, a number of nisms underlying this phenomenon remain unknown, groups have looked at obvious candidate genes, atboth genetic and environmental factors are thought to tempting to associate clear differences in metabolic be involved. phenotype with mutations or polymorphisms in known Failure of ␤ Cell Compensation genes. Genes encoding proteins involved in insulin sigIn addition to an increase in ␤ cell mass, the compensanaling, glucose transport, glycogen synthesis, fatty acid tory increase in insulin secretion during states of insulin uptake and synthesis, and adipocyte differentiation resistance is the result of elevated expression of certain have all yielded associations with diabetes, but in only genes encoding proteins of glucose metabolism. Both perhaps 2%-5% of patients, suggesting that such synmechanisms are evident in the Zucker fatty rat, which dromes are relatively rare. develops insulin resistance and hyperinsulinemia, withIn recent years, most investigators in this area have out progressing to hyperglycemia (Tokuyama et al., focused on identifying diabetes genes via positional 1995). In this rat, the increase in islet mass seems to cloning methods, looking for linkage between regions reflect ␤ cell proliferation, perhaps with some changes of chromosomal DNA that are shared in affected family in matrix proteins surrounding the ␤ cells. Increased members. A number of relatively uncommon monogenic expression of glucokinase and hexokinase also appears forms of the disease, known as maturity-onset diabetes to contribute to the hypersecretion of insulin, by increasof the young (MODY), have been attributed to mutations ing glucose phosphorylation, making more substrate resulting in ␤ cell dysfunction. These patients usually available for glycolysis. The signal that produces these present in adolescence to early adulthood, with defecchanges remains uncertain, but may be glucose itself, tive insulin secretion in response to glucose. Five of or perhaps even insulin, generating a positive feedback these genes include the glucose metabolizing enzyme loop.
glucokinase, transcription factors HNF1␣ and ␤, HNF4␣, Unlike the Zucker fatty rat, the male Zucker diabetic and insulin promoter factor 1 (IPF1) (Hattersley, 1998 ; fatty rat progresses to frank diabetes due to failure to Permutt and Hattersley, 2000) . These mutations can lead compensate adequately for insulin resistance, sugto moderate to significant reductions in insulin secretion, gesting a modifier gene present in one or the other strain with consequent development of hyperglycemia. While that directly impacts ␤ cell function. Studies on cell the incidence of these monogenic forms of diabetes is turnover in these animals suggest that the primary denot precisely known, it may represent up to 5% of all patients with Type 2 diabetes. fect lies not in an inability of ␤ cells to proliferate but A number of genomic scans have been carried out to opportunities for therapeutic intervention. Recent advances in mechanisms of signal transduction, cell differdefine the more common polygenic forms of the disease. Studies concentrating on several ethnic and racial groups entiation, and membrane trafficking have led to new approaches (Table 1) . A major challenge of these efforts have identified a series of linkages across several regions of the genome. The first of these studies to be will include the need to specifically target molecules that impact on metabolism, without interfering with or completed focused on 170 Mexican-American families in Starr County, Texas, identifying a linkage on Ch2p37 activating other pathways that might lead to unacceptable side effects. Thus, it will be necessary to keep in (Hanis et al., 1996) . This locus was shown to require another locus on Ch15 for its effects. Although it is possible that these results reflect an largely unexplained, there are clues about some therapeutic targets, including proteins involved in the regulaindirect modulation of insulin resistance through changes in the metabolic milieu, they suggest that PPAR␥ activation of Glut4 vesicle docking described above. Another approach emerges from insights into glucose transport tors might not act purely as agonists for the receptor, but may also antagonize effects of natural ligands at in exercise. Recent studies suggest that the stimulation of Glut4 translocation in response to acute exercise or some sites (Camp et al., 2000) . Indeed, some TZDs are partial agonists of PPAR␥, and different TZDs induce hypoxia utilizes an insulin-independent pathway, possibly involving activation of AMP-activated kinase (Hayaan overlapping but distinct set of genes, suggesting that the conformation and activity of the TZD/PPAR␥ shi et al., 1998). Although the protein substrates of this kinase are unknown at present, this enzyme may reprecomplex might depend upon ligand structure or promoter context (Camp et al., 2000) . These data have led sent an attractive target for development of activators, which might also produce beneficial effects on lipids to the concept of the selective PPAR modulator (Olefsky and Saltiel, 2000) . This model expands the signaling (Kemp et al., 1999). Although untested, it is also possible that direct stimurepertoire of a specific nuclear receptor, since it would allow a response to a given endogenous ligand in a lation of glycogen synthesis might mimic or enhance insulin action. As described above, the phosphorylation way that is gene context specific. Moreover, different endogenous ligands, working through the same nuclear state of glycogen synthase and phosphorylase are controlled by the kinases GSK3 and PKA, and the phosphareceptor, could hypothetically lead to different responses in different tissues. Thus, identification of the tase PP1, all of which are potential therapeutic targets. Although glucose transport is clearly the rate-limiting appropriate "molecular signature" for a ligand, based on binding properties, molecular structure, cataloged step in glucose utilization, it is possible that the stimulation of glycogen synthesis might sensitize cells to insuchanges in gene expression in target tissues, coactivator and corepressor binding patterns, and in vivo phenolin, via a "pull" mechanism. Appropriate targeting of molecules that modulate the activities of these enzymes type regarding efficacy and side effect profile, might lead to the development of rationally designed antidiais critical, since they are involved in a number of other processes that critically control cell growth and apoptobetic drugs that are greatly improved over the TZDs. Targeting Insulin Signaling sis. In this regard, it will be important to take into consideration the scaffolding roles played by the glycogenThe insulin receptor and its signaling pathways are also a fertile area for drug development. Efforts are underway targeting subunits. ␤ Cell Targets to identify small molecule mimics of the receptor (Zhang et al., 1999) , although whether these will lead to effective
The most widely used antidiabetic drugs stimulate insulin secretion and are typified by the sulfonylurea class, treatments of insulin resistance remains uncertain. The receptor might also be negatively regulated by protein which directly inhibit the ␤ cell isoform of a specific K channel. However, while these drugs are effective in tyrosine phosphatases. Elevated expression of PTP1b 
